Developing a biologic to treat enlarged prostates.
Industry: Health Care
First Day Return: -17.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/15/2013 |
Offer Price | $5.00 |
Price Range $5.00 - $5.00 | |
Offer Shares (mm) | 13.0 |
Deal Size ($mm) | $65 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 08/16/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $65 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | La Jolla, CA, United States |
Founded | 2002 |
Employees at IPO | 10 |
Website www.sophirisbio.com |